UB Paderborn / Katalog / Suche / in CDI

Glucagon-like peptide 1 (GLP-1)

Molecular metabolism (Germany), 2019-12, Vol.30, p.72-130

2019

Volltextzugriff (PDF)

Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice

Peptides (New York, N.Y. : 1980), 2007-05, Vol.28 (5), p.981-987

2007

Volltextzugriff (PDF)

The effects of traditional antidiabetic plants on in vitro glucose diffusion

Nutrition research (New York, N.Y.), 2003-03, Vol.23 (3), p.413-424

2003

Volltextzugriff (PDF)

239 Establishment of an F508del pseudoislet model for the study of CF-related diabetes

Journal of cystic fibrosis, 2012-06, Vol.11, p.S117-S117

2012

Volltextzugriff (PDF)

PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometry

Biochimica et biophysica acta. General subjects, 2023-06, Vol.1867 (6), p.130359-130359, Article 130359

2023

Volltextzugriff (PDF)

Pituitary adenylate cyclase-activating peptide (PACAP): Assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential

Peptides (New York, N.Y. : 1980), 2006-06, Vol.27 (6), p.1349-1358

2006

Volltextzugriff (PDF)

C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function

Biochemical pharmacology, 2018-12, Vol.158, p.95-102

2018

Volltextzugriff (PDF)

Positive interplay between FFAR4/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice

Peptides (New York, N.Y. : 1980), 2024-07, Vol.177, p.171218, Article 171218

2024

Volltextzugriff (PDF)

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes

Peptides (New York, N.Y. : 1980), 2024-06, Vol.176, p.171196-171196, Article 171196

2024

Volltextzugriff (PDF)

Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential

Biochemical pharmacology, 2018-09, Vol.155, p.264-274

2018

Volltextzugriff (PDF)

Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice

Molecular and cellular endocrinology, 2015-02, Vol.401, p.120-129

2015

Volltextzugriff (PDF)

Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance

Diabetes, obesity & metabolism, 2010-10, Vol.12 (10), p.891-899

2010

Volltextzugriff (PDF)

Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

International Journal of Obesity, 2013-05, Vol.37 (5), p.678-684

2013

Volltextzugriff (PDF)

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis

European journal of pharmaceutical sciences, 2020-01, Vol.142, p.105104-105104, Article 105104

2020

Volltextzugriff (PDF)

Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions

Peptides (New York, N.Y. : 1980), 2018-02, Vol.100, p.219-228

2018

Volltextzugriff (PDF)

A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice

Biochemical pharmacology, 2020-01, Vol.171, p.113723-113723, Article 113723

2020

Volltextzugriff (PDF)

Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice

European journal of pharmacology, 2019-12, Vol.865, p.172733-172733, Article 172733

2019

Volltextzugriff (PDF)

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

Peptides (New York, N.Y. : 1980), 2020-03, Vol.125, p.170251-170251, Article 170251

2020

Volltextzugriff (PDF)

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

International Journal of Obesity, 2010-08, Vol.34 (8), p.1341-1344

2010

Volltextzugriff (PDF)

Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action

British journal of nutrition, 2007-03, Vol.97 (3), p.514-521

2007

Volltextzugriff (PDF)

Stable oxyntomodulin analogues exert positive effects on hippocampal neurogenesis and gene expression as well as improving glucose homeostasis in high fat fed mice

Molecular and cellular endocrinology, 2015-09, Vol.412, p.95-103

2015

Volltextzugriff (PDF)

Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice

Molecular and cellular endocrinology, 2016-08, Vol.431, p.133-144

2016

Volltextzugriff (PDF)

Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells

Biochemical and biophysical research communications, 2013-02, Vol.431 (1), p.14-18

2013

Volltextzugriff (PDF)

Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice

Molecular and cellular endocrinology, 2016-01, Vol.420, p.37-45

2016

Volltextzugriff (PDF)

Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice

Biochimica et biophysica acta, 2015-01, Vol.1850 (1), p.80-87

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Glucagon-like peptide 1 (GLP-1)

Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice

The effects of traditional antidiabetic plants on in vitro glucose diffusion

239 Establishment of an F508del pseudoislet model for the study of CF-related diabetes

PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometry

Pituitary adenylate cyclase-activating peptide (PACAP): Assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential

C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function

Positive interplay between FFAR4/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes

Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential

Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice

Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance

Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis

Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions

A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice

Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action

Stable oxyntomodulin analogues exert positive effects on hippocampal neurogenesis and gene expression as well as improving glucose homeostasis in high fat fed mice

Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice

Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells

Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice

Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice

Suchergebnisse filtern